4//SEC Filing
Rudoltz Marc 4
Accession 0000899243-21-042702
CIK 0001819133other
Filed
Nov 2, 8:00 PM ET
Accepted
Nov 3, 4:15 PM ET
Size
5.5 KB
Accession
0000899243-21-042702
Insider Transaction Report
Form 4
Rudoltz Marc
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-11-01+350,000→ 350,000 totalExercise: $12.91Exp: 2031-11-01→ Common Stock (350,000 underlying)
Footnotes (1)
- [F1]This option shall vest and become exercisable over a four-year period, at a rate of 25% on October 18, 2022, with the remaining option shares vesting in 36 equal monthly installments thereafter.
Documents
Issuer
Tango Therapeutics, Inc.
CIK 0001819133
Entity typeother
Related Parties
1- filerCIK 0001890661
Filing Metadata
- Form type
- 4
- Filed
- Nov 2, 8:00 PM ET
- Accepted
- Nov 3, 4:15 PM ET
- Size
- 5.5 KB